HIMS Hims Hers Health Inc
Company Analysis
Latest News
π’ Hims Hers Health is trading 5.2% up today as investors buy the dip following FTC lawsuit
β’ Hims Hers Health is trading 5.2% up at $28.45 as investors buy the recent dip. β’ The rebound follows a multi-day pullback, largely triggered by a Federal...
π’ Hims Hers Health is trading 4.6% up today as investors buy the dip amid a broader market rebound
Hims Hers Health is trading at $26.14 (up 4.6%) as investors buy the recent dip following a sharp multi-day pullback earlier this week. β’ The move appears...
π΄ Hims Hers Health is trading 11.9% down today as profit-taking extends after July rally
Hims Hers Health is trading 11.9% down at $25.84 as investors extend a recent bout of profit-taking following a sharp rally earlier in July. β’ The stock's...
π΄ Hims Hers Health is trading 6.9% down today amid profit-taking after recent gains
Hims Hers Health is trading 6.9% down at $28.19 as investors lock in profits following a significant recent rally. β’ The decline follows a sharp run-up in...
π’ Hims Hers Health is trading 5.3% up
Hims Hers Health is trading at $29.57, up 5.3% from a comparison close of $28.09 during regular trading. This is a price-action follow-up, so a separate...
Hims Stock Whipsaws 10% as FDA Peptide Vote Lands Mid-Selloff β Can the Telehealth Giant Turn Regulatory Relief Into Real Revenue?
Shares of Hims & Hers Health plunged as much as 10.7% to $29.23 on July 24 as traders locked in profits from a sharp multi-week rally and braced for the...
π΄ Hims Hers Health is trading 10.7% down today on profit-taking and FDA peptide meeting caution
Hims Hers Health is trading 10.7% down at $29.23 as traders lock in gains after a sharp multi-week rally and position cautiously ahead of upcoming regulatory...
π΄ Hims Hers Health is trading 4.4% down today on profit-taking and caution ahead of FDA peptide meeting
Hims Hers Health is trading 4.4% down at $31.30 as investors lock in gains following a strong recent rally and ahead of a pivotal regulatory event. β’ The...
π’ Hims Hers Health is trading 10.3% up
Hims Hers Health is trading at $34.95, up 10.3% from a comparison close of $31.68 during regular trading. This is a price-action follow-up, so a separate...
π΄ Hims Hers Health is trading 4.2% down today as investors rotate out of growth names
Hims Hers Health is trading at $32.26 (down 4.2%) as investors rotate out of growth names during a broad tech-led risk-off move. β’ The stock is sliding...
π΄ Hims Hers Health is trading 4.4% down today amid broad market risk-off sentiment and tech weakness
Hims Hers Health is trading at $32.20 (-4.40%) today as broad market risk-off sentiment and a sharp selloff in technology shares weigh on growth stocks. β’...
π΄ Hims Hers Health Inc is trading 4.71% down
HIMS is trading at $35.42, down 4.71%.
π’ Hims Hers Health Inc is trading 4.04% up
HIMS is trading at $36.57, up 4.04%.
Hims & Hers falls, as BofA flags weight-loss churn risk
Hims & Hers Health (HIMS) shares fell for a third consecutive day following a Bank of America Securities warning. Analysts identified significant risks to the...
π΄ Hims Hers Health is trading 4% down today on Amazon competition fears and broader risk-off sentiment
Hims Hers Health is trading at $34.03 (-4.01%) as macroeconomic pressures and competitive threats weigh on the stock. β’ Broader risk sentiment is being driven...
π΄ HIMS is trading 4.2% down today as profit-taking extends its post-rally pullback
HIMS is trading 4.2% down at $34.66, extending a sharp two-day pullback following last weekβs powerful rally. β’ The decline follows a significant run-up...
π΄ HIMS is trading 4.3% down today as it extends a pullback from recent highs amid weaker index futures
HIMS is trading 4.3% down at $34.60 in pre-market, extending Tuesdayβs decline as the stock pulls back from a sharp multi-day rally. β’ The move appears to be...
π΄ HIMS is trading 4.2% down today as it pulls back from its July 6 rally
HIMS is trading at $36.66 (4.2% down) as the stock pulls back from its July 6 rally amid broader market weakness. β’ The decline follows a 4.02% move higher in...
Hims & Hers Enters $400M Receivables Purchase Agreement with JPMorgan Chase
Hims & Hers Health, Inc. announced that its subsidiaries have entered into a Master Receivables Purchase Agreement (RPA) with JPMorgan Chase Bank, N.A. The...
π’ HIMS makes sharp 10.1% jump
HIMS is trading at $38.17, up 10.1% versus the comparison close of $34.67 during regular trading. This is a price-movement alert; no separate company-specific...